Literature DB >> 11340615

Gene rearrangements in radiation-induced thyroid carcinogenesis.

H M Rabes1.   

Abstract

BACKGROUND: Radiation is an accepted risk factor for thyroid carcinogenesis in children. Recent observations in large cohorts of children and young adults who developed papillary thyroid carcinomas (PTC) related to accidental radiation exposure after the Chernobyl reactor accident revealed typical genetic aberrations shedding light on genetic determinants and mechanisms of radiation-induced carcinogenesis. PROCEDURE: A molecular genetic analysis was performed on 191 post-Chernobyl PTC by RT-PCR, multiplex PCR, DNA sequencing, and in some cases 5'RACE. Determination of point mutations was by means of PCR and either allele-specific oligonucleotide hybridization or SSCP and DNA sequencing.
RESULTS: In various sporadic thyroid tumor types of adults structural genetic aberrations have been found involving mutations of RAS (codon 12, 13, 61), p53 (exons 5 to 8), Gsalpha (codon 201 and 227), and, at a low prevalence, the receptor tyrosine kinases RET or NTRK1. In contrast, in radiation-induced PTC of children RET rearrangements are by far the most prevalent genetic aberrations. In these RET rearrangements, the transmembrane and extracellular domains of RET are lost, and are replaced by parts of other genes at the 5' end. These genes always contain coiled-coil domains with dimerization potential and lead to constitutive, ligand-independent activation of the ret tyrosine kinase domain at the 3' end of the fusion product. The most frequent radiation-induced RET gene fusions involve the ELE1 (ARA70) gene, a transcription coactivator of the androgen receptor (PTC3), and H4, a gene of unknown function (PTC1). Both rearrangements originate from DNA double strand breaks with repair by intrachromosomal balanced paracentric inversion and recombination by illegitimate DNA endjoining at small stretches of homologous nucleotide sequences and direct or inverted repeats, without significant breakpoint clusters in the involved introns. In addition, five different RET-fused genes, RIalpha, GOLGA5, HTIF, RFG7 and RFG8, have been detected leading to the PTC2, 5, 6, 7 and 8 types of RET rearrangements, respectively. Each fusion leads, in principle, to the same effect: The ret tyrosine kinase is uncoupled from its stringent physiological regulation by replacement of its 5' end and is aberrantly activated by the 5' parts of fused genes in thyrocytes that do not normally express ret tyrosine kinase. Ectopic ret expression, clonal expansion and early invasion are peculiar to the affected cells. The RET-fused gene is obviously decisive for modulating tumor development: ELE1/RET rearrangements lead to most rapid tumor progression and are related to the solid variant of PTC, in contrast to H4/RET rearrangements connected with papillary or follicular variants of PTC.
CONCLUSIONS: Typical genetic aberrations are produced by radioiodine uptake in the juvenile thyroid gland. They act as determinants of phenotype, biology, and clinical course of radiation-induced papillary thyroid carcinomas. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11340615     DOI: 10.1002/mpo.1133

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  10 in total

1.  Distinguishing molecular markers in thyroid tumors: a tribute to Dr. Orlo Clark.

Authors:  Martha A Zeiger
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

Review 2.  Values of molecular markers in the differential diagnosis of thyroid abnormalities.

Authors:  T M P B Tennakoon; M Rushdhi; A D C U Ranasinghe; R S Dassanayake
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-22       Impact factor: 4.553

3.  The effect of cervical X-irradiation on activity index of thyrocytes and plasma TSH: a pre-clinical model for radiation-induced thyroid damage.

Authors:  H M van Santen; J E Van Dijk; H Rodermond; F Vansenne; N Meertens; J Haveman; E Endert; J J M De Vijlder; T Vulsma
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

4.  Drosophila Cancer Models Identify Functional Differences between Ret Fusions.

Authors:  Sarah Levinson; Ross L Cagan
Journal:  Cell Rep       Date:  2016-09-13       Impact factor: 9.423

5.  Genomic copy number analysis of Chernobyl papillary thyroid carcinoma in the Ukrainian-American Cohort.

Authors:  Martin Selmansberger; Herbert Braselmann; Julia Hess; Tetiana Bogdanova; Michael Abend; Mykola Tronko; Alina Brenner; Horst Zitzelsberger; Kristian Unger
Journal:  Carcinogenesis       Date:  2015-08-29       Impact factor: 4.944

6.  Papillary carcinoma of the thyroid gland in a child of thyrotoxicosis patient receiving radioactive iodine therapy: report of a case.

Authors:  Surasak Sangkhathat; Sakda Patrapinyokul; Piyawan Chiengkriwate; Supika Kritsaneepaiboon; Kanita Kayasut; Teerapol Pramphapa; Matinee Maipang
Journal:  Pediatr Surg Int       Date:  2008-04-15       Impact factor: 1.827

Review 7.  RET/PTC rearrangement in thyroid tumors.

Authors:  Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 8.  Role of p53 in Regulating Radiation Responses.

Authors:  Ryuji Okazaki
Journal:  Life (Basel)       Date:  2022-07-21

Review 9.  Radiation-induced thyroid cancer: what we have learned from chernobyl.

Authors:  Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2006       Impact factor: 4.056

10.  Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma.

Authors:  Aleksandra Pfeifer; Dagmara Rusinek; Jadwiga Żebracka-Gala; Agnieszka Czarniecka; Ewa Chmielik; Ewa Zembala-Nożyńska; Bartosz Wojtaś; Bartłomiej Gielniewski; Sylwia Szpak-Ulczok; Małgorzata Oczko-Wojciechowska; Jolanta Krajewska; Joanna Polańska; Barbara Jarząb
Journal:  Genes Chromosomes Cancer       Date:  2019-02-18       Impact factor: 5.006

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.